Healthy volunteers to test drug absorption in new study
NCT ID NCT07466550
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This early-phase study will enroll 60 healthy volunteers to compare how the drug risankizumab behaves in the body when given as a shot under the skin versus through an IV. The main goals are to measure side effects and drug levels in the blood. No treatment or health benefit is expected for participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CenExel ACT- Anaheim Clinical Trials /ID# 281821
RECRUITINGAnaheim, California, 92801, United States
-
Cpmi /Id# 281783
RECRUITINGMiami, Florida, 33172, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?